Literature DB >> 17127702

Adenovirus-mediated expression of BMP-7 suppresses the development of liver fibrosis in rats.

Kohji Kinoshita1, Yuji Iimuro, Kohji Otogawa, Shizuya Saika, Yutaka Inagaki, Yuji Nakajima, Norifumi Kawada, Jiro Fujimoto, Scott L Friedman, Kazuo Ikeda.   

Abstract

BACKGROUND: Liver cirrhosis, which is caused by the accumulation of extracellular matrix materials, is a serious clinical problem that can progress to hepatic failure. Transforming growth factor-beta (TGFbeta) plays a pivotal role in extracellular matrix production, but bone morphogenetic protein (BMP)-7, a member of the TGFbeta superfamily, can antagonise the fibrogenic activity of TGFbeta. AIM: In this study, we examined whether adenovirus-mediated overexpression of BMP-7 (Ad-BMP-7) antagonised the effect of TGFbeta in vitro and in vivo. METHODS AND
RESULTS: In primary cultured rat stellate cells and the LX-2 human stellate cell line, induction of BMP-7 by Ad-BMP-7 infection decreased the expression of collagen 1A2 mRNA and smooth muscle alpha-actin in the presence or absence of TGFbeta, via Smad 1/5/8 phosphorylation. BMP-7 triggered the mRNA expression of inhibitors of differentiation 2 (Id2) in LX-2. Although endogenous expression of BMP-7 was hardly detectable, Smad1 and Id2 overexpression increased BMP-7 expression in LX-2. A liver fibrosis model was induced by the repetitive intraperitoneal injection of thioacetamide (200 mg/kg body weight) twice per week for up to 7 weeks. In rats administered Ad-BMP-7 via the tail vein, hydroxyproline content and the areas stained by Sirius red dye in the liver were significantly reduced compared to controls. Ad-Id2 also reduced fibrosis.
CONCLUSION: These data demonstrate that BMP-7, Smad 1/5/8 and Ids interact to antagonise hepatic fibrogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17127702      PMCID: PMC1942155          DOI: 10.1136/gut.2006.092460

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  47 in total

1.  Inhibition of costimulation allows for repeated systemic administration of adenoviral vector in rhesus monkeys.

Authors:  H Haegel-Kronenberger; K Haanstra; C Ziller-Remy; A P Ortiz Buijsse; J Vermeiren; F Stoeckel; S W Van Gool; J L Ceuppens; M Mehtali; M De Boer; M Jonker; Louis Boon
Journal:  Gene Ther       Date:  2004-02       Impact factor: 5.250

Review 2.  Perisinusoidal stellate cells (fat-storing cells, interstitial cells, lipocytes), their related structure in and around the liver sinusoids, and vitamin A-storing cells in extrahepatic organs.

Authors:  K Wake
Journal:  Int Rev Cytol       Date:  1980

3.  Akt activation protects rat liver from ischemia/reperfusion injury.

Authors:  Nobuko Harada; Etsuro Hatano; Naoki Koizumi; Takashi Nitta; Masanori Yoshida; Naritaka Yamamoto; David A Brenner; Yoshio Yamaoka
Journal:  J Surg Res       Date:  2004-10       Impact factor: 2.192

4.  Repeated adenoviral administration into the biliary tract can induce repeated expression of the original gene construct in rat livers without immunosuppressive strategies.

Authors:  K Tominaga; S Kuriyama; H Yoshiji; A Deguchi; Y Kita; F Funakoshi; T Masaki; K Kurokohchi; N Uchida; T Tsujimoto; H Fukui
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

Review 5.  Id proteins in development, cell cycle and cancer.

Authors:  Marianna B Ruzinova; Robert Benezra
Journal:  Trends Cell Biol       Date:  2003-08       Impact factor: 20.808

6.  GATA- and Smad1-dependent enhancers in the Smad7 gene differentially interpret bone morphogenetic protein concentrations.

Authors:  Hassina Benchabane; Jeffrey L Wrana
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

7.  Id2 and Id3 define the potency of cell proliferation and differentiation responses to transforming growth factor beta and bone morphogenetic protein.

Authors:  Marcin Kowanetz; Ulrich Valcourt; Rosita Bergström; Carl-Henrik Heldin; Aristidis Moustakas
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

8.  Role of phosphatidylinositol 3-kinase in the development of hepatocyte preconditioning.

Authors:  Rita Carini; Maria Grazia De Cesaris; Roberta Splendore; Gianluca Baldanzi; Maria Paola Nitti; Elisa Alchera; Nicoletta Filigheddu; Cinzia Domenicotti; Maria Adelaide Pronzato; Andrea Graziani; Emanuele Albano
Journal:  Gastroenterology       Date:  2004-09       Impact factor: 22.682

9.  Bone morphogenetic protein-7 signals opposing transforming growth factor beta in mesangial cells.

Authors:  Shinong Wang; Raimund Hirschberg
Journal:  J Biol Chem       Date:  2004-03-26       Impact factor: 5.157

Review 10.  Molecular basis of hepatic fibrosis.

Authors:  Alex Y Hui; Scott L Friedman
Journal:  Expert Rev Mol Med       Date:  2003-02-14       Impact factor: 5.600

View more
  59 in total

1.  Characterization of Inhibitor of differentiation (Id) proteins in human cornea.

Authors:  Rajiv R Mohan; Brandie R Morgan; Govindaraj Anumanthan; Ajay Sharma; Shyam S Chaurasia; Frank G Rieger
Journal:  Exp Eye Res       Date:  2015-12-19       Impact factor: 3.467

2.  Non-invasive biomarkers for monitoring the fibrogenic process in liver: a short survey.

Authors:  Axel-M Gressner; Chun-Fang Gao; Olav-A Gressner
Journal:  World J Gastroenterol       Date:  2009-05-28       Impact factor: 5.742

3.  The Role of Signal Transducer and Activator of Transcription 5 and Transforming Growth Factor-β1 in Hepatic Fibrosis Induced by Chronic Hepatitis C Virus Infection in Egyptian Patients.

Authors:  Mona A Abu El Makarem; Ghada M El-Sagheer; Moustafa A Abu El-Ella
Journal:  Med Princ Pract       Date:  2018-01-31       Impact factor: 1.927

4.  Transforming Growth Factor-β and Bone Morphogenetic Protein 2 Regulation of MicroRNA-200 Family in Chronic Pancreatitis.

Authors:  Peter Yu; Ka Liu; Xuxia Gao; Harry Karmouty-Quintana; Jennifer M Bailey; Yanna Cao; Tien C Ko
Journal:  Pancreas       Date:  2018-02       Impact factor: 3.327

Review 5.  Cellular mechanisms of tissue fibrosis. 1. Common and organ-specific mechanisms associated with tissue fibrosis.

Authors:  Michael Zeisberg; Raghu Kalluri
Journal:  Am J Physiol Cell Physiol       Date:  2012-12-19       Impact factor: 4.249

Review 6.  [Liver fibrosis - pathogenesis and novel therapeutic approaches].

Authors:  F Tacke; R Weiskirchen
Journal:  Internist (Berl)       Date:  2010-01       Impact factor: 0.743

7.  BMP2 inhibits TGF-β-induced pancreatic stellate cell activation and extracellular matrix formation.

Authors:  Xuxia Gao; Yanna Cao; Wenli Yang; Chaojun Duan; Judith F Aronson; Cristiana Rastellini; Celia Chao; Mark R Hellmich; Tien C Ko
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-02-21       Impact factor: 4.052

8.  Endothelial to mesenchymal transition via transforming growth factor-beta1/Smad activation is associated with portal venous stenosis in idiopathic portal hypertension.

Authors:  Azusa Kitao; Yasunori Sato; Seiko Sawada-Kitamura; Kenichi Harada; Motoko Sasaki; Hiroyasu Morikawa; Susumu Shiomi; Masao Honda; Osamu Matsui; Yasuni Nakanuma
Journal:  Am J Pathol       Date:  2009-07-16       Impact factor: 4.307

9.  Exogenous bone morphogenetic protein-7 reduces hepatic fibrosis in Schistosoma japonicum-infected mice via transforming growth factor-β/Smad signaling.

Authors:  Bo-Lin Chen; Jie Peng; Qing-Fu Li; Min Yang; Yuan Wang; Wei Chen
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

10.  Parathyroid Hormone-Related Protein Interacts With the Transforming Growth Factor-β/Bone Morphogenetic Protein-2/Gremlin Signaling Pathway to Regulate Proinflammatory and Profibrotic Mediators in Pancreatic Acinar and Stellate Cells.

Authors:  Vandanajay Bhatia; Yanna Cao; Tien C Ko; Miriam Falzon
Journal:  Pancreas       Date:  2016 May-Jun       Impact factor: 3.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.